SOPHiA GENETICS SA

SOPH

CH1125843347

Software

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
4.95 ^USD	-2.17%		-0.80%	+5.10%

May. 29	Sector Update: Health Care Stocks Fall Late Afternoon	MT
May. 29	Sophia Genetics Rallies Wednesday after Partnering with Microsoft, Nvidia on Whole Genome Analytics Platform	MT

SOPHiA GENETICS Reiterates Earnings Guidance for the Full Year 2024

May 07, 2024 at 06:45 am EDT

SOPHiA GENETICS reiterated earnings guidance for the full year 2024. Based on information as of May 7, 2024, SOPHiA GENETICS is reaffirming previously provided guidance of: revenue between $78 million and $81 million, representing growth of 25% to 30% compared to full year 2023 revenue.

Latest news about SOPHiA GENETICS SA

Sector Update: Health Care Stocks Fall Late Afternoon	May. 29	MT
Sophia Genetics Rallies Wednesday after Partnering with Microsoft, Nvidia on Whole Genome Analytics Platform	May. 29	MT
SOPHiA GENETICS SA to Launch New Whole Genome Sequencing Capabilities	May. 29	CI
SOPHiA GENETICS Announces Instituto Mário Penna as New Customer	May. 20	CI
Transcript : SOPHiA GENETICS SA, Q1 2024 Earnings Call, May 07, 2024	May. 07
SOPHiA GENETICS SA Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
SOPHiA GENETICS Reiterates Earnings Guidance for the Full Year 2024	May. 07	CI
Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering	Apr. 23	MT
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa	Apr. 23	CI
SOPHiA GENETICS Announces Unilabs Using Its AI Technology to Detect Homologous Recombination Deficiency	Apr. 17	CI
Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools	Apr. 04	MT
Sophia Genetics SA Announces Laboratorio Barnafi-Krause Is Live on the Sophia DDM? Platform	Apr. 02	CI
SOPHiA GENETICS Announces First Homologous Recombination Deficiency Customer in Canada	Mar. 20	CI
Transcript : SOPHiA GENETICS SA Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 through Mar-14-2024	Mar. 12
Transcript : SOPHiA GENETICS SA, Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
SOPHiA GENETICS SA Provides Earnings Guidance for 2024	Mar. 05	CI
SOPHiA GENETICS SA Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 05	CI
North American Morning Briefing : S&P 500 Futures -2-	Mar. 05	DJ
Sophia Genetics, AstraZeneca Expand Project to Improve Access to Ovarian Cancer Testing in Spain	Feb. 07	MT
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain	Feb. 07	CI
Sophia Genetics Supports Genetic Testing in Brazil	Jan. 25	CI
SOPHiA GENETICS Enhances RareCyte Inc. Precision Biology Services Portfolio	Jan. 18	CI
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India	Jan. 14	CI
Transcript : SOPHiA GENETICS SA Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-11-2024 09:00 AM	Jan. 11
SOPHiA GENETICS SA Provides Preliminary Earnings Guidance for the Full Year Ending December 31, 2023	Jan. 10	CI

Chart SOPHiA GENETICS SA

Duration

Period

More charts

Company Profile

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Sector

Software

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for SOPHiA GENETICS SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.95 USD

Average target price

8.667 USD

Spread / Average Target

+75.08%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
SOPHIA GENETICS SA	+5.10%	324M
MICROSOFT CORPORATION	+12.71%	3,150B
SYNOPSYS INC.	+10.98%	87.56B
CADENCE DESIGN SYSTEMS, INC.	+8.10%	80.72B
DASSAULT SYSTÈMES SE	-16.04%	52.81B
PALANTIR TECHNOLOGIES INC.	+35.76%	51.91B
THE TRADE DESK, INC.	+30.86%	46.06B
ATLASSIAN CORPORATION	-31.32%	42.52B
SEA LIMITED	+78.94%	41.62B
TAKE-TWO INTERACTIVE SOFTWARE, INC.	+2.37%	28.24B

Other Software

SOPHiA GENETICS SA

Equities

SOPH

CH1125843347

Software

SOPHiA GENETICS Reiterates Earnings Guidance for the Full Year 2024

EPS Revisions